Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
11.61
-0.41 (-3.41%)
May 13, 2025, 4:00 PM - Market closed
Zymeworks Employees
As of December 31, 2024, Zymeworks had 286 total employees, including 280 full-time and 6 part-time employees. The number of employees increased by 8 or 2.88% compared to the previous year.
Employees
286
Change (1Y)
8
Growth (1Y)
2.88%
Revenue / Employee
$326,517
Profits / Employee
-$397,476
Market Cap
809.03M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ZYME News
- 5 days ago - Zymeworks Inc. (ZYME) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Zymeworks Provides Corporate Update and Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 15 days ago - Zymeworks: A Strong Buy With Newly-Approved Cancer Drug, Excellent Financials, And Expansive Pipeline - Seeking Alpha
- 15 days ago - Zymeworks: Poised For Growth With Platform Validation - Seeking Alpha
- 18 days ago - Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting - GlobeNewsWire
- 23 days ago - Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development - GlobeNewsWire
- 27 days ago - Zymeworks to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 - GlobeNewsWire
- 7 weeks ago - Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewsWire